It was very interesting to identify EZH2 and SMYD3 as the most significantly changed and overexpressed histone modifiers in prostate cancer, since the two modifications are antagonistic and correspond to repressive (H3K27me3) and active (H3K4me3) gene transcription, respectively. The gene discussed is EZH2; the disease is prostate cancer.